Union Pharmacist results, Q4 2023
Net profit, assets, equity and cash flow for Q4 2023, against the same period a year earlier, from the published financial statements.
Net profit-45.99 millionEGP · −12485.8% vs the same period a year earlier
Total assets53.11 millionEGP · −22.0% vs the same period a year earlier
Shareholders' equity10.17 millionEGP · −14.3% vs the same period a year earlier
Operating cash flow-74.49 thousandEGP · −111.1% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q4 2023 was about -45.99 million EGP, down −12485.8% from -365 thousand EGP in Q4 2022.
- Total assets at the end of Q4 2023 were about 53.11 million EGP, and shareholders' equity about 10.17 million EGP.
- Operating cash flow for Q4 2023 was negative at 74.49 thousand EGP.
Key lines against the same period a year earlier
This periodQ4 2022Change
Net profit-45.99 million-365 thousand−12485.8%
Gross profit—138 thousand—
Total assets53.11 million68.12 million−22.0%
Total liabilities42.94 million56.25 million−23.7%
Shareholders' equity10.17 million11.87 million−14.3%
Total liabilities and equity53.11 million68.12 million−22.0%
Operating cash flow-74.49 thousand674 thousand−111.1%
Investing cash flow—-122 thousand—
Net change in cash-74.49 thousand552 thousand−113.5%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy